Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Neoantigen Cancer Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06751953
What this trial is testing

Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Early research (Phase 1)Active Not RecruitingNCT04015700
What this trial is testing

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 9
Early research (Phase 1)Active Not RecruitingNCT04161755
What this trial is testing

Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 29
Early research (Phase 1)Looking for participantsNCT04147078
What this trial is testing

Personalized DC Vaccine for Postoperative Cancer

Who this might be right for
Gastric CancerHepatocellular CarcinomaNon-Small-Cell Lung Cancer+1 more
Sichuan University 80
Not applicableStudy completedNCT05158621
What this trial is testing

A Screening Study Targeting Tumor-specific Antigens

Who this might be right for
Metastatic Colorectal CancerStage II/III Colon Cancer
Gritstone bio, Inc. 22
Not applicableLooking for participantsNCT06682117
What this trial is testing

A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor

Who this might be right for
TreatmentNeoantigenVaccine+1 more
Fudan University 9
Testing effectiveness (Phase 2)Study completedNCT06614140
What this trial is testing

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Who this might be right for
CancerSolid Tumor, Adult
Seqker Biosciences, Inc. 8
Not applicableLooking for participantsNCT06751966
What this trial is testing

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Early research (Phase 1)Not Yet RecruitingNCT07300475
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Washington University School of Medicine 30
Early research (Phase 1)UnknownNCT04810910
What this trial is testing

Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Resectable Pancreatic Cancer
Zhejiang Provincial People's Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Early research (Phase 1)UnknownNCT02956551
What this trial is testing

Personalized DC Vaccine for Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sichuan University 20
Testing effectiveness (Phase 2)Study completedNCT03639714
What this trial is testing

A Personalized Neoantigen Cancer Vaccine

Who this might be right for
Non Small Cell Lung CancerColorectal CancerGastroesophageal Adenocarcinoma+1 more
Gritstone bio, Inc. 29
Testing effectiveness (Phase 2)WithdrawnNCT04267237
What this trial is testing

The Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche
Very early researchNot Yet RecruitingNCT06735508
What this trial is testing

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Guangdong Provincial People's Hospital 40
Very early researchLooking for participantsNCT06980155
What this trial is testing

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine 60
Not applicableAvailableNCT07612930
What this trial is testing

Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
Early research (Phase 1)Looking for participantsNCT06026774
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms

Who this might be right for
Digestive System Neoplasms
Sir Run Run Shaw Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365280
What this trial is testing

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
ZSky Biotech Inc 78
Next Page